Ron Bentsur

2019 - UroGen Pharma Ltd.

In 2019, Ron Bentsur earned a total compensation of $8.1K as Former Chief Executive Officer at UroGen Pharma Ltd., a 100% decrease compared to previous year.

Compensation breakdown

Salary$5,812
Other$2,326
Total$8,138

Bentsur received $5.8K in salary, accounting for 71% of the total pay in 2019.

Bentsur also received $2.3K in other compensation.

Rankings

In 2019, Ron Bentsur's compensation ranked 13,943rd out of 13,971 executives tracked by ExecPay.

ClassificationRankingPercentile
All
13,943
out of 13,971
0th
Division
Manufacturing
5,696
out of 5,701
0th
Major group
Chemicals And Allied Products
2,199
out of 2,200
0th
Industry group
Drugs
1,885
out of 1,886
0th
Industry
Pharmaceutical Preparations
1,397
out of 1,398
0th

Pay ratio

Ron Bentsur's Pay$8,138
Median Employee's Pay$223,867
Pay Ratio

to 1

In 2019, the annual total compensation of Ron Bentsur was $8,138.

The annual total compensation of the median employee at UroGen Pharma Ltd. was $223,867.

The ratio of Ron Bentsur's pay to the pay of median employee was therefore to one.

Source: SEC filing on April 29, 2020.

Bentsur's colleagues

We found four more compensation records of executives who worked with Ron Bentsur at UroGen Pharma Ltd. in 2019.

2019

Elizabeth Barrett

UroGen Pharma Ltd.

Chief Executive Officer

2019

Peter Pfreundschuh

UroGen Pharma Ltd.

Chief Financial Officer

2019

Stephen Mullennix

UroGen Pharma Ltd.

Chief Operating Officer

2019

Mark Schoenberg

UroGen Pharma Ltd.

Chief Medical Officer

News

You may also like